Literature DB >> 18609198

Incidence of peritonsillar abscess and relationship to age and gender: retrospective study.

Stefan Risberg1, Peter Engfeldt, Svante Hugosson.   

Abstract

The incidence of peritonsillitis is not very well known. A retrospective study was performed at the Ear, Nose and Throat clinic (ENT) at the University Hospital of Orebro Sweden. We studied every case from 2002 to 2004 and related it to a well-defined catchment area of 179,200 inhabitants. We identified 283 events of peritonsillitis, of which 85 were defined as peritonsillar cellulitis (PTC). Peritonsillar abscess (PTA) was found in 198 events in patients between 7 and 82 y of age. 13 patients had 2 episodes of PTA during the study period. The overall incidence was 37/100,000/y. The highest incidence was found between 14 and 21 y of age, with 124/100,000/y. The male: female ratio was 1: 1. Affected females were younger than males (p=0.04), and the peak incidence was earlier for females. This may be due to differences in immunological response, owing to hormonal maturation. The annual incidence of PTA was higher in this study than found in previous studies, which is probably attributable to the fact that our study identified almost all cases in the population.

Entities:  

Mesh:

Year:  2008        PMID: 18609198     DOI: 10.1080/00365540802195226

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  21 in total

1.  Smoking promotes peritonsillar abscess.

Authors:  Tejs Ehlers Klug; Maria Rusan; Kim Katrine Bjerring Clemmensen; Kurt Fuursted; Therese Ovesen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

2.  Bacteriology of peritonsillar abscess in patients over 40 years--a neglected age group.

Authors:  Haim Gavriel; Yitzhak Golan; Tsilia Lazarovitch; Ephraim Eviatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-08       Impact factor: 2.503

3.  Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitals.

Authors:  D Lepelletier; V Pinaud; P Le Conte; C Bourigault; N Asseray; F Ballereau; J Caillon; C Ferron; C Righini; E Batard; G Potel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-04       Impact factor: 3.267

4.  Who ends up having tonsillectomy after peritonsillar infection?

Authors:  Johanna Wikstén; Maija Hytönen; Anne Pitkäranta; Karin Blomgren
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-29       Impact factor: 2.503

5.  [Bilateral peritonsillar abscess with lymph node abscess in a infant. A rare case].

Authors:  F Bast; H Köhler; K-D Sparr; T Schrom
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

6.  Peritonsillar abscess: remember to always think twice.

Authors:  Jochen P Windfuhr; Alexandra Zurawski
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-21       Impact factor: 2.503

7.  Microarray identification of bacterial species in peritonsillar abscesses.

Authors:  J E Wikstén; S Laakso; M Mäki; A A Mäkitie; A Pitkäranta; K Blomgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-30       Impact factor: 3.267

8.  Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender.

Authors:  T E Klug
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-29       Impact factor: 3.267

9.  Tonsillitis in children: unnecessary laboratory studies and antibiotic use.

Authors:  Antti Kunnamo; Matti Korppi; Merja Helminen
Journal:  World J Pediatr       Date:  2015-11-07       Impact factor: 2.764

10.  Utility of Smartphone Telemedical Consultations for Peritonsillar Abscess Diagnosis and Triage.

Authors:  Jonathan R Mallen; Manan Udayan Shah; Ryan Drake; Kathryn Kreicher; Todd Falcone; Nicholas Karter; Scott Schoem; Christopher Grindle; Stephen Wolfe; Chia-Ling Kuo; Jinjian Mu; Seth Lotterman; Gregory Bonaiuto
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-10-01       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.